Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy

Bibliography

• Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. 2nd edition. Oxford Press; New York: 2007
   Google Scholar
• Merikangas KE, Akiskal HS, Angst J, Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64:543-52
   PubMed Web of Science ®Google Scholar
• Janicak PG, Marder S, Pavuluri M. Principles and Practice of Psychopharmacotherapy. 5th edition. Lippincott Williams & Wilkins; Philadelphia, PA: 2011
   Google Scholar
• Janicak PG, Rado JT. Quetiapine for bipolar depression. Expert Opin Pharmacother 2011;12:1643-51
   PubMed Web of Science ®Google Scholar
• Gao K, Kemp DE, Ganocy SJ, Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol 2008;28:203-9
   PubMed Web of Science ®Google Scholar
• Nasrallah HA, Brecher M, Paulsson B. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord 2006;8:467-74
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Brechner M, Paulsson B, Quetiapine or haloperidol as monotherapy for bipolar mania – a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005;15:573-85
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J, A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005;66:111-21
   PubMed Web of Science ®Google Scholar
• McElroy SL, Martens BE, Winstanley EL, Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. J Affect Disord 2010;124:157-63
   PubMed Web of Science ®Google Scholar
• Cutler AJ, Datto C, Nordenhem A, Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Clin Ther 2011;33:1643-58
   PubMed Web of Science ®Google Scholar
• Li H, Ma C, Wang G, Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. Curr Med Res Opin 2008;24:1-10
   PubMed Web of Science ®Google Scholar
• Sachs G, Chengappa KN, Suppes T, Quetiapine with lithium or divalproex for the treatement of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004;6:213-23
   PubMed Web of Science ®Google Scholar
• Yatham LN, Paulsson B, Mullen J, Vagero AM. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004;24:599-606
   PubMed Web of Science ®Google Scholar
• Yatham LN, Vieta E, Young AH, A double-blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Int Clin Psychopharmacol 2007;22:212-20
   PubMed Web of Science ®Google Scholar
• DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:1216-23
   PubMed Web of Science ®Google Scholar
• DelBello MP, Kowatch RA, Adler CM, A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006;45:305-13
   PubMed Web of Science ®Google Scholar
• Brown ES, Garza M, Carmody TJ. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 2008;69:701-5
   PubMed Web of Science ®Google Scholar
• Stedman M, Pettinati HM, Brown ES, A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 2010;34:1822-31
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Eggens I, Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 2008;109:251-63
   PubMed Web of Science ®Google Scholar
• Suppes T, Vieta E, Liu S, Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (Trial 127). Am J Psychiatry 2009;166:474-88
   Web of Science ®Google Scholar
• Weisler RH, Nolen WA, Neijber A, Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). J Clin Psychiatry 2011;72:1452-64
   PubMed Web of Science ®Google Scholar
• Altamura AC, Mundo E, Dell’Osso B, Quetiapine and classical mood stabilizers in the long-term treatment of bipolar disorder: a 4-year follow-up naturalistic study. J Affect Disord 2008;110:135-41
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Kelley ME, Rosenquist KL, Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord 2008;105:305-10
   PubMed Web of Science ®Google Scholar
• Langosch JM, Drieling T, Biederman NC, Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J Clin Psychopharmacol 2008;28:555-60
   PubMed Web of Science ®Google Scholar
• McConville B, Carrero L, Sweitzer D, Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol 2003;13:75-82
   PubMed Web of Science ®Google Scholar
• Duffy A, Milin R, Grof P. Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine. BMC Psychiatry 2009;9:4-10
   PubMed Web of Science ®Google Scholar
• Vieta E, Gunther O, Locklear J, Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2011;14:1029-49
   PubMed Web of Science ®Google Scholar
• Adler CM, Fleck DE, Brecher M, Strakowski SM. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. J Affect Disord 2007;100(Suppl 1):15-22
   Google Scholar
• Grunze H, Vieta E, Goodwin GM, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010;11:81-109
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Schaffer A, Canadian Network for Mood Anxiety Treatments (CNAMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder. Bipolar Disord 2009;11:225-55
   PubMed Web of Science ®Google Scholar
• Vieta E, Goldberg JF, Mullen J, Quetiapine in the treatment of acute mania: target dose for efficacious treatment. J Affect Disord 2007;100(Suppl 1):23-31
   PubMed Web of Science ®Google Scholar